$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Buy | M | 5.96 | 8,750 | 52,150 | 73,082 | 64.3 K to 73.1 K (+13.60 %) |
| Mar 07 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.56 | 335,827 | 4,553,814 | 18,424,424 | 18.1 M to 18.4 M (+1.86 %) |
| Mar 06 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.90 | 100,000 | 1,389,500 | 18,088,597 | 18 M to 18.1 M (+0.56 %) |
| Jan 25 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 20,000 | 45,800 | 110,000 | |
| Jan 25 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 16.80 | 20,000 | 336,000 | 85,409 | 105.4 K to 85.4 K (-18.97 %) |
| Jan 25 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 2.29 | 20,000 | 45,800 | 105,409 | 85.4 K to 105.4 K (+23.42 %) |
| Jan 24 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 10.21 | 32,500 | 331,825 | 0 | |
| Jan 24 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 15.92 | 32,500 | 517,371 | 154,100 | 186.6 K to 154.1 K (-17.42 %) |
| Jan 24 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 10.21 | 32,500 | 331,825 | 186,600 | 154.1 K to 186.6 K (+21.09 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Option Exercise | A | 15.67 | 8,284 | 129,810 | 8,284 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Grant | A | 0.00 | 5,732 | 0 | 40,469 | 34.7 K to 40.5 K (+16.50 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | A | 15.67 | 18,224 | 285,570 | 18,224 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Payment of Exercise | F | 15.67 | 2,953 | 46,274 | 64,332 | 67.3 K to 64.3 K (-4.39 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Grant | A | 0.00 | 12,609 | 0 | 67,285 | 54.7 K to 67.3 K (+23.06 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | General Counsel & C ... | Option Exercise | A | 15.67 | 39,762 | 623,071 | 39,762 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | General Counsel & C ... | Payment of Exercise | F | 15.67 | 6,112 | 95,775 | 80,025 | 86.1 K to 80 K (-7.10 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | General Counsel & C ... | Grant | A | 0.00 | 27,511 | 0 | 86,137 | 58.6 K to 86.1 K (+46.93 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 15.67 | 180 | 2,821 | 180 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 15.67 | 39,762 | 623,071 | 39,762 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 125 | 0 | 125 | 0 to 125 |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 15.67 | 6,286 | 98,502 | 85,409 | 91.7 K to 85.4 K (-6.86 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 27,511 | 0 | 91,695 | 64.2 K to 91.7 K (+42.86 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 15.67 | 43,075 | 674,985 | 43,075 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 15.67 | 6,239 | 97,765 | 496,771 | 503 K to 496.8 K (-1.24 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 29,803 | 0 | 503,010 | 473.2 K to 503 K (+6.30 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 15.67 | 43,075 | 674,985 | 43,075 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Payment of Exercise | F | 15.67 | 7,302 | 114,422 | 117,622 | 124.9 K to 117.6 K (-5.85 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Grant | A | 0.00 | 29,803 | 0 | 124,924 | 95.1 K to 124.9 K (+31.33 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 15.67 | 56,329 | 882,675 | 56,329 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 15.67 | 9,345 | 146,436 | 154,100 | 163.4 K to 154.1 K (-5.72 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 38,973 | 0 | 163,445 | 124.5 K to 163.4 K (+31.31 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 15.67 | 154,076 | 2,414,371 | 154,076 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 106,603 | 0 | 434,604 | 328 K to 434.6 K (+32.50 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 7.51 | 4,366 | 32,789 | 5,634 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 2.81 | 5,000 | 14,050 | 5,000 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | S | 15.00 | 9,366 | 140,490 | 5,814 | 15.2 K to 5.8 K (-61.70 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Buy | M | 15.00 | 9,366 | 140,490 | 15,180 | 5.8 K to 15.2 K (+161.09 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Option Exercise | M | 6.13 | 10,000 | 61,300 | 65,000 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Sell | S | 14.72 | 10,000 | 147,191 | 34,737 | 44.7 K to 34.7 K (-22.35 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Buy | M | 14.72 | 10,000 | 147,191 | 44,737 | 34.7 K to 44.7 K (+28.79 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 5,000 | 11,450 | 130,000 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 14.71 | 5,000 | 73,559 | 64,184 | 69.2 K to 64.2 K (-7.23 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 14.71 | 5,000 | 73,559 | 69,184 | 64.2 K to 69.2 K (+7.79 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.45 | 10,000 | 24,500 | 54,000 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 14.72 | 10,000 | 147,181 | 95,121 | 105.1 K to 95.1 K (-9.51 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 14.72 | 10,000 | 147,181 | 105,121 | 95.1 K to 105.1 K (+10.51 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | M | 10.36 | 8,000 | 82,880 | 0 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 14.72 | 8,000 | 117,723 | 54,676 | 62.7 K to 54.7 K (-12.76 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Buy | M | 14.72 | 8,000 | 117,723 | 62,676 | 54.7 K to 62.7 K (+14.63 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 10.53 | 10,000 | 105,300 | 0 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 7.15 | 10,000 | 71,500 | 0 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Sell | S | 15.00 | 20,000 | 300,002 | 5,814 | 25.8 K to 5.8 K (-77.48 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Buy | M | 15.00 | 20,000 | 300,002 | 25,814 | 5.8 K to 25.8 K (+344.00 %) |
| Jan 02 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 5,920 | 20,898 | 1,538 | |
| Jan 02 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 13,050 | 46,067 | 7,458 | |
| Jan 02 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 5,920 | 87,320 | 328,001 | 333.9 K to 328 K (-1.77 %) |
| Jan 02 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 5,920 | 87,320 | 333,921 | 328 K to 333.9 K (+1.80 %) |
| Jan 02 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 13,050 | 192,497 | 328,001 | 341.1 K to 328 K (-3.83 %) |
| Jan 02 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 13,050 | 192,497 | 341,051 | 328 K to 341.1 K (+3.98 %) |
| Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.21 | 506 | 5,166 | 0 | |
| Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.21 | 65,075 | 664,416 | 506 | |
| Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.51 | 506 | 6,836 | 328,001 | 328.5 K to 328 K (-0.15 %) |
| Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 13.51 | 506 | 6,836 | 358,507 | 358 K to 358.5 K (+0.14 %) |
| Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.51 | 65,075 | 878,929 | 328,001 | 393.1 K to 328 K (-16.56 %) |
| Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 13.51 | 65,075 | 878,929 | 393,076 | 328 K to 393.1 K (+19.84 %) |
| Dec 13 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.21 | 6,991 | 71,378 | 65,581 | |
| Dec 13 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.21 | 5,215 | 53,245 | 0 | |
| Dec 13 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.52 | 12,206 | 164,973 | 328,001 | 340.2 K to 328 K (-3.59 %) |
| Dec 13 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 13.52 | 12,206 | 164,973 | 340,207 | 328 K to 340.2 K (+3.72 %) |
| Dec 06 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.21 | 47,213 | 482,045 | 77,787 | |
| Dec 06 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.61 | 47,213 | 642,734 | 328,001 | 375.2 K to 328 K (-12.58 %) |
| Dec 06 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 13.61 | 47,213 | 642,734 | 375,214 | 328 K to 375.2 K (+14.39 %) |
| Dec 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 5,000 | 11,450 | 135,000 | |
| Dec 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 13.59 | 5,000 | 67,937 | 64,184 | 69.2 K to 64.2 K (-7.23 %) |
| Dec 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 13.59 | 5,000 | 67,937 | 69,184 | 64.2 K to 69.2 K (+7.79 %) |
| Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 19,013 | 67,116 | 20,508 | |
| Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 52,722 | 186,109 | 39,521 | |
| Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.76 | 19,013 | 280,544 | 328,001 | 347 K to 328 K (-5.48 %) |
| Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.76 | 19,013 | 280,544 | 347,014 | 328 K to 347 K (+5.80 %) |
| Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 52,722 | 777,650 | 328,001 | 380.7 K to 328 K (-13.85 %) |
| Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 52,722 | 777,650 | 380,723 | 328 K to 380.7 K (+16.07 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.52 | 40,000 | 100,800 | 6,224 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 14.25 | 40,000 | 570,132 | 95,121 | 135.1 K to 95.1 K (-29.60 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 14.25 | 40,000 | 570,132 | 135,121 | 95.1 K to 135.1 K (+42.05 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 5,000 | 11,450 | 140,000 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 14.25 | 5,000 | 71,268 | 64,184 | 69.2 K to 64.2 K (-7.23 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 14.25 | 5,000 | 71,268 | 69,184 | 64.2 K to 69.2 K (+7.79 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 6.10 | 14,582 | 88,950 | 35,418 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 2.94 | 35,612 | 104,699 | 9,388 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 14.25 | 50,194 | 715,360 | 473,207 | 523.4 K to 473.2 K (-9.59 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 14.25 | 50,194 | 715,360 | 523,401 | 473.2 K to 523.4 K (+10.61 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 7.15 | 5,000 | 35,750 | 5,000 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 10.53 | 5,000 | 52,650 | 5,000 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | S | 14.25 | 10,000 | 142,534 | 5,814 | 15.8 K to 5.8 K (-63.24 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Buy | M | 14.25 | 10,000 | 142,534 | 15,814 | 5.8 K to 15.8 K (+172.00 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | M | 10.21 | 7,000 | 71,470 | 0 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 14.25 | 7,000 | 99,740 | 54,676 | 61.7 K to 54.7 K (-11.35 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Buy | M | 14.25 | 7,000 | 99,740 | 61,676 | 54.7 K to 61.7 K (+12.80 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 47,135 | 166,387 | 92,243 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 22,160 | 78,225 | 139,378 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.19 | 192,133 | 612,904 | 20,972 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 2.52 | 165,000 | 415,800 | 0 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 3,462 | 12,221 | 161,538 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.38 | 13,622 | 59,664 | 136,378 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 5,783 | 37,300 | 131,024 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 47,135 | 695,241 | 328,001 | 375.1 K to 328 K (-12.56 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 47,135 | 695,241 | 375,136 | 328 K to 375.1 K (+14.37 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 22,160 | 326,867 | 328,001 | 350.2 K to 328 K (-6.33 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 22,160 | 326,867 | 350,161 | 328 K to 350.2 K (+6.76 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.25 | 380,000 | 5,414,810 | 328,001 | 708 K to 328 K (-53.67 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.25 | 380,000 | 5,414,810 | 708,001 | 328 K to 708 K (+115.85 %) |
| Sep 28 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | C | 3.19 | 1,395 | 4,450 | 213,105 | |
| Sep 28 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | P | 14.36 | 1,395 | 20,032 | 328,001 | 326.6 K to 328 K (+0.43 %) |
| Aug 25 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 12.64 | 3,000 | 37,920 | 3,000 | |
| Jul 14 2017 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.25 | 1,500,000 | 18,375,000 | 17,888,597 | 16.4 M to 17.9 M (+9.15 %) |
| Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 8.79 | 1,231 | 10,820 | 473,207 | 474.4 K to 473.2 K (-0.26 %) |
| Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 8.79 | 5,005 | 43,994 | 326,606 | 331.6 K to 326.6 K (-1.51 %) |
| Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 8.79 | 3,003 | 26,396 | 124,472 | 127.5 K to 124.5 K (-2.36 %) |
| Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 30,000 | 68,700 | 111,969 | |
| Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 10.00 | 30,000 | 300,000 | 64,184 | 94.2 K to 64.2 K (-31.85 %) |
| Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 10.00 | 30,000 | 300,000 | 94,184 | 64.2 K to 94.2 K (+46.74 %) |
| Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | M | 8.79 | 1,629 | 14,319 | 64,184 | 65.8 K to 64.2 K (-2.48 %) |
| Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Payment of Exercise | F | 8.79 | 1,554 | 13,660 | 95,371 | 96.9 K to 95.4 K (-1.60 %) |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | WHEELER CRAIG A | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | WHEELER CRAIG A | Director | Grant | A | 0.00 | 5,814 | 0 | 5,814 | 0 to 5.8 K |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 5,814 | 0 | 17,747 | 11.9 K to 17.7 K (+48.72 %) |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Grant | A | 0.00 | 5,814 | 0 | 5,814 | 0 to 5.8 K |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 5,814 | 0 | 5,814 | 0 to 5.8 K |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Grant | A | 0.00 | 5,814 | 0 | 5,814 | 0 to 5.8 K |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Grant | A | 0.00 | 5,814 | 0 | 5,814 | 0 to 5.8 K |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Grant | A | 0.00 | 5,814 | 0 | 5,814 | 0 to 5.8 K |
| May 23 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 8.00 | 29,914 | 239,312 | 474,438 | 504.4 K to 474.4 K (-5.93 %) |
| Mar 03 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 8.00 | 49,050 | 392,400 | 127,475 | 176.5 K to 127.5 K (-27.79 %) |
| Feb 09 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 6.00 | 25,000 | 150,000 | 534,266 | 559.3 K to 534.3 K (-4.47 %) |
| Jan 17 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 6.00 | 25,000 | 150,000 | 559,266 | 584.3 K to 559.3 K (-4.28 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Option Exercise | A | 5.13 | 42,372 | 217,368 | 42,372 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Grant | A | 0.00 | 30,487 | 0 | 34,737 | 4.3 K to 34.7 K (+717.34 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | A | 5.13 | 42,372 | 217,368 | 42,372 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Grant | A | 0.00 | 30,487 | 0 | 54,676 | 24.2 K to 54.7 K (+126.04 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | General Counsel & C ... | Option Exercise | A | 5.13 | 70,621 | 362,286 | 70,621 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | General Counsel & C ... | Grant | A | 0.00 | 50,813 | 0 | 57,063 | 6.3 K to 57.1 K (+813.01 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 5.13 | 70,621 | 362,286 | 70,621 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 50,813 | 0 | 65,813 | 15 K to 65.8 K (+338.75 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 5.13 | 70,621 | 362,286 | 70,621 |